Avanir Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100000005729

Total reported 2019–2025

$39.5M

#199 of 2,960 reporting companies — 0% of all reported industry payments

$6.69M in general payments across 79,399 records, plus $32.8M in research funding across 3,719 records.

How it breaks down

General payments $6,688,438

Research funding $32,837,486

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.